Authorization

Advisory - Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk

OTTAWA, Jan. 17, 2020 /CNW/ -
Advisory - Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk
Summary

Product: PMS-Nystatin Oral Suspension 100,000 units/mL (DIN 00792667), Lot 681044, Expires 30-11-2021.



Issue: Product may contain clumps or jelly-like material, which may lead to choking. Newborns, infants and people with difficulty swallowing are particularly at risk.



What to do: If, even after the product is shaken well, your product still contains clumps greater than 1 millimetre in size or jelly-like material, return it to your pharmacy for safe disposal and to obtain a replacement.

Issue
Health Canada is advising Canadians that Pharmascience Inc. is recalling one lot of
PMS-Nystatin Oral Suspension, because it may contain clumps or jelly-like material that may pose a choking risk. Newborns, infants and people with difficulty swallowing are particularly at risk.PMS-Nystatin Oral Suspension normally contains small visible particles and, as noted in the user instructions, it should be shaken well before each use to mix the drug evenly. For the affected lot, clumps greater than 1 millimetre (the size of a poppy seed) or jelly-like material may persist even after the product is shaken well.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2020    »
ПнВтСрЧтПтСбВс
 12
3456789
10111213141516
17181920212223
242526272829